Your browser doesn't support javascript.
loading
Ibrutinib plus rituximab and lenalidomide for primary intestinal diffuse large B-cell lymphoma relapsed after anti-CD19 CAR-T cell therapy: a case report.
Li, Changyou; Zhang, Xiyuan; Zhu, Danni; Bu, Xiaocui; Wang, Ling; Zhao, Peng.
Afiliação
  • Li C; Biotherapy Center, Affiliated Qingdao Central Hospital of Qingdao University, 127 Siliunan Road, Qingdao, 266042, China.
  • Zhang X; Department of Hematology, Affiliated Qingdao Central Hospital of Qingdao University, 127 Siliunan Road, Qingdao, 266042, China.
  • Zhu D; Biotherapy Center, Affiliated Qingdao Central Hospital of Qingdao University, 127 Siliunan Road, Qingdao, 266042, China.
  • Bu X; The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao, China.
  • Wang L; Department of Hematology, Affiliated Qingdao Central Hospital of Qingdao University, 127 Siliunan Road, Qingdao, 266042, China. wldoctor@126.com.
  • Zhao P; Biotherapy Center, Affiliated Qingdao Central Hospital of Qingdao University, 127 Siliunan Road, Qingdao, 266042, China. zp8102@126.com.
Ann Hematol ; 102(12): 3625-3627, 2023 12.
Article em En | MEDLINE | ID: mdl-37608197
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Receptores de Antígenos Quiméricos Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Receptores de Antígenos Quiméricos Idioma: En Ano de publicação: 2023 Tipo de documento: Article